Genomic instability in scleroderma

Asian Pacific Journal of Allergy and Immunology

Volumn 22, Issue 2-3, 2004, Pages 153-158

  Roberts Thomson, P J ^a   Male, D A ^b   Walker, J G ^a   Cox, S R ^a   Shen, X ^b   Smith, M D ^a   Ahern, M J ^a   Turner, D R ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FLUORESCENT DYE; GLYCOPHORIN A; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BLOOD GROUP; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE DURATION; DOCUMENTATION; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE LOSS; GENETIC DAMAGE; GENETIC STABILITY; HETEROZYGOSITY; HUMAN; MITOTIC RECOMBINATION; MUTATION RATE; ONSET AGE; PROGENY; SCLERODERMA; SOMATIC MUTATION; STEM CELL;

ADOLESCENT; AGED; ALLELES; FEMALE; FLOW CYTOMETRY; GENOMIC INSTABILITY; GLYCOPHORIN; HUMANS; MALE; MIDDLE AGED; MUTATION; SCLERODERMA, SYSTEMIC;

EID: 8644292538     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am 1996 Nov; 22: 751-64.
2. Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AASS, Walker JG, MacFarlane JG, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Int Med J 2001; 31: 220-9.
3. Roberts-Thomson PJ, Jones ME, Walker JG, MacFarlane JG, Smith MD, Ahern MJ. Stochastic processes in the causation of rheumatic disease. J Rheumatol 2002; 29: 2628-34.
4. Emerit I, Housset J, De Grouchy J, Camus JP. Chromosomal breakage in diffuse scleroderma. A study of 27 patients. Eur J Clin Biol Res 1971; 16: 684-94.
5. Pan SF, Rodnan GP, Seutsch M, Wald N. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects. J Lab Clin Med 1975; 86: 300-8.
6. Sherer GK, Jackson BB, Le Roy EC. Chromosome breakage and sister chromatid exchange frequencies in scleroderma. Arthritis Rheum 1981; 24: 1409-13.
7. Rittner G, Schwanitz G, Baur MP, Black CM, Welsh KI, Juhnl P. et al. Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes. Hum Genet 1988; 81: 64-70.
8. Migliore L, Bevilacqua C, Scarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus and systemic sclerosis patients. Mutagenesis 1999; 14: 227-31.
9. Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 1996; 35: 732-7.
10. Wolff DJ, Needleman BW, Wasserman SS, Schwarts S. Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991; 18: 837-40.
11. Artlett CM, Black CM, Briggs DC, Stephens C, Welsh KI. DNA allelic alterations with VNTR loci of scleroderma families. Br J Rheumatol 1996; 35: 1216-22.
12. Hill CL, Nguyen A-M, Roder D, Roberts-Thomson PJ. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003; 62: 728-31.
13. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma: classification, subset and pathogenesis. J Rheumatol 1988; 25: 688-94.
14. Jensen RH, Bigbee WL. Direct immunofluorescence labelling provides an improved method for the glycophorin-A somatic cell mutation assay. Cytometry 1196; 23: 337-43.
15. Grist SA, McCarron M, Kutlaca A, Turner DR, Morley AA. In vivo somatic mutation: frequency and spectrum with age. Mutat Res 1992; 266: 189-96.
16. Holt D, Dreimanis M, Pfeiffer M, Firgaira F, Morley A, Turner D. Inter-individual variation in mitotic recombination. An J Hum Genet 1999; 65: 1423-7.
17. Trainor KJ, Wigmore DJ, Chrysostomou A, Dempsey JL, Seshadri R, Morley AA. Mutation frequency in human lymphocytes increases with age. Mech Aging Dev 1984; 27: 83-6.
18. Diot E, Lesire V, Guilmot JL, et al. Systemic sclerosis and occupational risk factors: as case-control study. Occup Environ Med 2002; 59: 545-9.
19. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000; 112-113: 421-32.
20. +/+ mice. Toxicol Appl Pharmacol 1995; 134: 155-60.
21. Sprung CN, Matthews LJ, McKay MJ. DNA repair deficiencies: connecting carcinogenesis and sensitivity to ionising radiation. Today's Life Science 2002; 14: 40-4.
22. Englert H, Small-McMahon J, Chambers P, et al. Familial risk estimation in systemic sclerosis. Aust NZ J Med 1999; 29: 36-7.
23. Sakkas LI, Moore DF, Akritidis NC, Cancer in families with systemic sclerosis. Am J Med Sci 1995; 310: 223-5.
24. Begg CB. Cancer, genes and the environment (letter). N Eng J Med 2000; 343: 1495.